IL6 and hydrops fetalis: Among investigated inflammatory biomarkers, the majority of studies focused on hsCRP and IL-6 as clinically applicable inflammatory biomarkers for risk assessment showing strong and large-scale evidence of their predictive and prognostic utility in HF.